GPS Wealth Strategies Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Sell |
64,925
-2,000
| -3% | -$9.34K | 0.03% | 252 |
|
|
2025
Q1 | $367K | Hold |
66,925
| – | – | 0.05% | 215 |
|
|
2024
Q4 | $227K | Buy |
66,925
+3,900
| +6% | +$13.2K | 0.03% | 274 |
|
|
2024
Q3 | $180K | Buy |
63,025
+1,000
| +2% | +$2.85K | 0.02% | 324 |
|
|
2024
Q2 | $140K | Hold |
62,025
| – | – | 0.02% | 332 |
|
|
2024
Q1 | $137K | Hold |
62,025
| – | – | 0.02% | 317 |
|
|
2023
Q4 | $146K | Sell |
62,025
-2,000
| -3% | -$4.7K | 0.03% | 288 |
|
|
2023
Q3 | $119K | Hold |
64,025
| – | – | 0.02% | 326 |
|
|
2023
Q2 | $168K | Hold |
64,025
| – | – | 0.03% | 261 |
|
|
2023
Q1 | $104K | Hold |
64,025
| – | – | 0.02% | 342 |
|
|
2022
Q4 | $85.2K | Sell |
64,025
-1,000
| -2% | -$1.33K | 0.03% | 109 |
|
|
2022
Q3 | $101K | Hold |
65,025
| – | – | 0.03% | 304 |
|
|
2022
Q2 | $100K | Buy |
+65,025
| New | +$100K | 0.03% | 318 |
|
|
2022
Q1 | – | Sell |
-59,025
| Closed | -$173K | – | 1166 |
|
|
2021
Q4 | $173K | Buy |
59,025
+1,000
| +2% | +$2.93K | 0.04% | 228 |
|
|
2021
Q3 | $142K | Buy |
58,025
+9,000
| +18% | +$22K | 0.04% | 236 |
|
|
2021
Q2 | $200K | Buy |
49,025
+2,000
| +4% | +$8.16K | 0.05% | 203 |
|
|
2021
Q1 | $212K | Buy |
47,025
+1,000
| +2% | +$4.51K | 0.06% | 182 |
|
|
2020
Q4 | $226K | Buy |
46,025
+525
| +1% | +$2.58K | 0.08% | 156 |
|
|
2020
Q3 | $270K | Buy |
+45,500
| New | +$270K | 0.11% | 123 |
|